Member Info for shatter

Starting to reek of desperation…

Nice to see that the directors are aware of the dire sp and helping to bolster it with their buys. If they are buying I don’t expect any news for a day or two..

If this is a vaccine “pause” what will happen to the sp if after discussions there is no further contract ? It’s only my opinion but it’s unlikely that Astra will need Oxb now.

Martin Diggle and other board members saw the writing on the wall. "Currently, total revenues in 2022 are expected to be lower than in 2021 (but significantly ahead of 2020) due to a pause in vaccine manufacturing activity while discussions with AstraZeneca continue on a potential extension of the supply agreement." An extension is pointless if no vaccine is needed. Without the vaccine revenue Oxb is indeed going to struggle. Oxb promises much but is lacking in delivery. Perhaps see a dead cat bounce but as Oxb have said they are going to be loss making for the foreseeable.

Can’t see anymore revenue from Astra considering there is a world glut of vaccines and other companies are cheaper and better suited to its manufacture. Oxb were very quiet about the ending of vaccine production !

Not great but news seems to be mostly built into the sp. Just where it goes from here over the coming months is a concern.

Maybe hedging his bets. :-)

It’s going to take some spectacular news tomorrow to reverse the sp direction. Fingers crossed for those holding.

A minor niggle is re-buying shares with my b share money will considerably raise my share price average. Can’t be helped..

Tried a dummy sell but could only get a negotiated trade this morning… very low volume I suspect. Considering averaging down..

That old saying” you can polish a ++++”

On consolidation day there ain’t going to be a period when you can buy the shares at 320-330p before the new consolidation price kicks in …, wise up! Do you really think this is the first share consolidation that has ever taken place?

Very succinct and concise. As you so rightly say going forward the share price will depend on profits and Aviva should also be a lot more attractive to Divi hunters. I am also intending to reinvest my Divi and b shares.

Whatever the reason it is great to see the sp rising. Thought we were heading for single figures but thankfully wrong.

Company treading water somewhat. Down 50% on this one but reckon we will see single figures so averaging down may have to wait for a change in fortunes. Good products but just can’t sell them..

should read ‘to date’. Results probably in the next few weeks.

Last year it was announced on the 15 March 21 for the 15 April 21 but no mention of results so date that I can find.

Reported in December… there now seems to be a world glut of vaccines with some nine major players in the picture.
The world's largest vaccine maker will halve the production of its Covid-19 vaccine because it has no fresh orders, its top-ranking executive has said.
India's Serum Institute is sitting on a stockpile of half a billion doses of Covishield, the local version of AstraZeneca's Vaxzevria jab, the firm's CEO Adar Poonawalla told CNBC-TV18.

Can’t put my finger on where I read about the vaccine. ADVFN makes some reference to it… hopefully incorrect ?

No more revenue from the vaccine! Can’t understand adding Homology to the portfolio? Cash burn must be a real drain on what’s left in the coffers. How is Oxb going to afford this and pay back Oaktree ? Just my musings. Had pondered over whether to buy back in but don’t see any upside. Will they have another fund raising? Answers on a postcard.